Could a pre-surgery drug boost bariatric surgery outcomes?
NCT ID NCT06721507
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This study looks at whether taking tirzepatide for three months before bariatric surgery can lower inflammation and lead to better weight loss and health improvements after surgery. About 50 adults with obesity and related health problems will either take the drug or not before their scheduled surgery. Researchers will compare inflammation levels, weight change, and complications within 30 days after surgery between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OBESITY-RELATED MEDICAL CONDITIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.